252 related articles for article (PubMed ID: 31298041)
1. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis.
Czaja AJ
Autoimmunity; 2019 Jun; 52(4):144-160. PubMed ID: 31298041
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Kumar P; Bhattacharya P; Prabhakar BS
J Autoimmun; 2018 Dec; 95():77-99. PubMed ID: 30174217
[TBL] [Abstract][Full Text] [Related]
3. Targeting T cell costimulation in autoimmune disease.
Stuart RW; Racke MK
Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
[TBL] [Abstract][Full Text] [Related]
4. Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance.
Gudi RR; Karumuthil-Melethil S; Perez N; Li G; Vasu C
Sci Rep; 2019 Aug; 9(1):12065. PubMed ID: 31427630
[TBL] [Abstract][Full Text] [Related]
5. Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.
Crepeau RL; Ford ML
Expert Opin Biol Ther; 2017 Aug; 17(8):1001-1012. PubMed ID: 28525959
[TBL] [Abstract][Full Text] [Related]
6. Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates.
Poirier N; Chevalier M; Mary C; Hervouet J; Minault D; Baker P; Ville S; Le Bas-Bernardet S; Dilek N; Belarif L; Cassagnau E; Scobie L; Blancho G; Vanhove B
J Immunol; 2016 Jan; 196(1):274-83. PubMed ID: 26597009
[TBL] [Abstract][Full Text] [Related]
7. Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis.
Czaja AJ; Montano-Loza AJ
Dig Dis Sci; 2019 Feb; 64(2):324-344. PubMed ID: 30370494
[TBL] [Abstract][Full Text] [Related]
8. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
[TBL] [Abstract][Full Text] [Related]
9. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
Daikh D; Wofsy D; Imboden JB
J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
[TBL] [Abstract][Full Text] [Related]
10. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
Fife BT; Bluestone JA
Immunol Rev; 2008 Aug; 224():166-82. PubMed ID: 18759926
[TBL] [Abstract][Full Text] [Related]
11. CD28/B7 costimulation: a review.
Greenfield EA; Nguyen KA; Kuchroo VK
Crit Rev Immunol; 1998; 18(5):389-418. PubMed ID: 9784967
[TBL] [Abstract][Full Text] [Related]
12. T-cell activation in autoimmune and inflammatory diseases.
Perkins DL
Curr Opin Nephrol Hypertens; 1998 May; 7(3):297-303. PubMed ID: 9617561
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 and autoimmunity: new insights into the dual regulator of tolerance.
Romo-Tena J; Gómez-Martín D; Alcocer-Varela J
Autoimmun Rev; 2013 Oct; 12(12):1171-6. PubMed ID: 23851140
[TBL] [Abstract][Full Text] [Related]
14. Alternative splice forms of CTLA-4 induced by antisense mediated splice-switching influences autoimmune diabetes susceptibility in NOD mice.
Mourich DV; Oda SK; Schnell FJ; Crumley SL; Hauck LL; Moentenich CA; Marshall NB; Hinrichs DJ; Iversen PL
Nucleic Acid Ther; 2014 Apr; 24(2):114-26. PubMed ID: 24494586
[TBL] [Abstract][Full Text] [Related]
15. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
Salomon B; Bluestone JA
Annu Rev Immunol; 2001; 19():225-52. PubMed ID: 11244036
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 and T cell activation.
Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
[TBL] [Abstract][Full Text] [Related]
17. T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity.
Foell J; Hewes B; Mittler RS
Curr Cancer Drug Targets; 2007 Feb; 7(1):55-70. PubMed ID: 17305478
[TBL] [Abstract][Full Text] [Related]
18. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
Nakajima A; Azuma M
Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells.
Zolov SN; Rietberg SP; Bonifant CL
Cytotherapy; 2018 Oct; 20(10):1259-1266. PubMed ID: 30309710
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of CTLA-4-Ig in tolerance induction.
Alegre ML; Fallarino F
Curr Pharm Des; 2006; 12(2):149-60. PubMed ID: 16454732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
